Evidence map›Paper›PMID 41134962›Full record

ArticleJournal of chemical information and modeling2025

SHARP: Generating Synthesizable Molecules via Fragment-Based Hierarchical Action-Space Reinforcement Learning for Pareto Optimization.

Jeonghyeon Kim, Seongok Ryu, Woohyeong Lee, Ansoo Lee, Hahnbeom Park, Chaok Seok

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jeonghyeon KimDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0009-0001-4468-5035
Seongok RyuGalux Inc., Seoul 08738, Republic of Korea.
Woohyeong LeeKorea Institute of Science and Technology, Seoul 02792, Republic of Korea.
Ansoo LeeKorea Institute of Science and Technology, Seoul 02792, Republic of Korea.ORCID 0000-0001-5608-4301
Hahnbeom ParkKorea Institute of Science and Technology, Seoul 02792, Republic of Korea.ORCID 0000-0002-7129-1912
Chaok SeokDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0002-1419-9888

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Designing drug-like molecules that satisfy multiple objectives-such as high binding affinity, synthesizability, and drug-likeness-poses a complex global optimization problem over an astronomically large chemical space. Existing deep learning-based molecular generative models often treat this task as distribution modeling, relying on atom-level autoregressive actions with less consideration of explicit optimization feedback. Consequently, they frequently generate invalid structures, converge to local optima, or produce synthetically infeasible candidates. Here, we introduce Synthesizable Hierarchical Action-space Reinforcement learning for Pareto optimization (SHARP), a molecular generator that addresses these limitations via a fragment-based hierarchical action space and reinforcement learning. SHARP ensures synthetic accessibility by applying action masks guided by a pretrained Synthesizability Estimation Model (SEM). The reinforcement learning (RL) policy is trained using a composite reward function integrating docking scores, pharmacophore matching, and solvent accessibility to generate functionally relevant and experimentally tractable molecules. Furthermore, across four lead optimization tasks-fragment growing, linker design, scaffold hopping, and side chain decoration-on a diverse receptor set, SHARP consistently outperforms prior methods in producing molecules at high affinity with reasonable synthesizability. These results demonstrate that reinforcement learning with a chemically intuitive action space design can be an effective solution to the optimization challenges in AI-driven drug discovery, offering a robust framework for rational molecular design in structure-based applications.

Indexed as

Deep LearningDrug DesignMolecular Docking Simulation

Identifiers

PMID41134962
PMCPMC12606630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.